Cargando…

Recombinant human C1 esterase inhibitor treatment for hereditary angioedema attacks in children

BACKGROUND: Attacks of hereditary angioedema (HAE) due to C1 esterase inhibitor deficiency (C1‐INH‐HAE) usually begin during childhood or adolescence. However, limited data are available regarding indications and modalities of treatment of children. This study evaluated recombinant human C1‐INH (rhC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reshef, Avner, Grivcheva‐Panovska, Vesna, Kessel, Aharon, Kivity, Shmuel, Klimaszewska‐Rembiasz, Maria, Moldovan, Dumitru, Farkas, Henriette, Gutova, Vaclava, Fritz, Stephen, Relan, Anurag, Giannetti, Bruno, Magerl, Markus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851822/ https://www.ncbi.nlm.nih.gov/pubmed/30993784 http://dx.doi.org/10.1111/pai.13065

Ejemplares similares

Recombinant human C1 esterase inhibitor for hereditary angioedema attacks: A European registry()
por: Valerieva, Anna, et al.
Publicado: (2021)

Hereditary Angioedema Attack in Utero and Treatment of the Mother and Fetus
por: Grivcheva-Panovska, Vesna, et al.
Publicado: (2020)

85 Clinical Efficacy of Recombinant Human C1 Inhibitor in Patients with Acute Hereditary Angioedema Attacks
por: Reshef, Avner, et al.
Publicado: (2012)

Continued icatibant use across recurrent attacks in adolescents with hereditary angioedema
por: Farkas, Henriette, et al.
Publicado: (2021)

Biomarkers in Hereditary Angioedema
por: Porebski, Grzegorz, et al.
Publicado: (2021)

Long‐term safety and effectiveness of berotralstat for hereditary angioedema: The open‐label APeX‐S study
por: Farkas, Henriette, et al.
Publicado: (2021)

Elevated D-dimers in attacks of hereditary angioedema are not associated with increased thrombotic risk
por: Reshef, A, et al.
Publicado: (2015)

Hereditary angioedema C1-esterase inhibitor replacement therapy and coexisting autoimmune disorders: findings from a claims database
por: Farkas, Henriette, et al.
Publicado: (2020)

Prodromes predict attacks of hereditary angioedema: Results of a prospective study
por: Leibovich‐Nassi, Iris, et al.
Publicado: (2022)

Mitigating Disparity in Health-care Resources Between Countries for Management of Hereditary Angioedema
por: Jindal, Ankur Kumar, et al.
Publicado: (2021)

Modeling Cost-Effectiveness of On-Demand Treatment for Hereditary Angioedema Attacks
por: Bernstein, Jonathan A., et al.
Publicado: (2020)

Long-term efficacy and safety of subcutaneous C1-inhibitor in women with hereditary angioedema: subgroup analysis from an open-label extension of a phase 3 trial
por: Levy, Donald S., et al.
Publicado: (2020)

Cost-effectiveness model for on-demand treatment of hereditary angioedema (HAE) attacks
por: Tyson, Christopher, et al.
Publicado: (2019)

Patient‐physician interactions in hereditary angioedema—Key learnings from the coronavirus disease 2019 pandemic
por: Maurer, Marcus, et al.
Publicado: (2023)

Management of upper airway edema caused by hereditary angioedema
por: Farkas, Henriette
Publicado: (2010)

84 Immuno-Safety of Recombinant Human C1 Inhibitor in Patients With Hereditary Angioedema: An Integrated Analysis
por: Hack, Erik, et al.
Publicado: (2012)

Hereditary Angioedema Caused By C1-Esterase Inhibitor Deficiency: A Literature-Based Analysis and Clinical Commentary on Prophylaxis Treatment Strategies
por: Gower, Richard G, et al.
Publicado: (2011)

Pediatric hereditary angioedema due to C1-inhibitor deficiency
por: Farkas, Henriette
Publicado: (2010)

Recombinant Human C1 Esterase Inhibitor in the Management of Hereditary Angioedema
por: Riedl, Marc
Publicado: (2015)

Editorial: C1 inhibitor deficiency and angioedema
por: Farkas, Henriette, et al.
Publicado: (2022)

Correction to: Mitigating Disparity in Healthcare Resources Between Countries for Management of Hereditary Angioedema
por: Jindal, Ankur Kumar, et al.
Publicado: (2021)

Angioedema Without Wheals: Challenges in Laboratorial Diagnosis
por: Grumach, Anete S., et al.
Publicado: (2021)

Screening for Plasminogen Mutations in Hereditary Angioedema Patients
por: Farkas, Henriette, et al.
Publicado: (2021)

WAO Guideline for the Management of Hereditary Angioedema
por: Craig, Timothy, et al.
Publicado: (2012)

Plasma-derived C1 esterase inhibitor pharmacokinetics and safety in patients with hereditary angioedema
por: Martinez-Saguer, Inmaculada, et al.
Publicado: (2023)

Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond
por: Agostoni, Angelo, et al.
Publicado: (2004)

Ecallantide is a novel treatment for attacks of hereditary angioedema due to C1 inhibitor deficiency
por: Farkas, Henriette, et al.
Publicado: (2011)

Anti-cholesterol antibody levels in hereditary angioedema
por: Varga, Lilian, et al.
Publicado: (2007)

Attenuated androgen discontinuation in patients with hereditary angioedema: a commented case series
por: Maurer, Marcus, et al.
Publicado: (2022)

Consequences of Misdiagnosed and Mismanaged Hereditary Angioedema Laryngeal Attacks: An Overview of Cases from the Romanian Registry
por: Moldovan, Dumitru, et al.
Publicado: (2018)

Clinical profile and treatment outcomes in patients with hereditary angioedema with normal C1 esterase inhibitor()
por: Jones, Douglas H., et al.
Publicado: (2022)

Recombinant human C1 esterase inhibitor as prophylactic treatment in idiopathic non‐histaminergic angioedema
por: Alizadeh Aghdam, Mehran, et al.
Publicado: (2022)

Molecular Dambusters: What Is Behind Hyperpermeability in Bradykinin-Mediated Angioedema?
por: Debreczeni, Márta L., et al.
Publicado: (2021)

Current challenges and future opportunities in patient‐focused management of hereditary angioedema: A narrative review
por: Grumach, Anete S., et al.
Publicado: (2023)

Case Title: 45 year-old male with recurrent angioedema: WAO international case-based discussions
por: Leiding, Jennifer W, et al.
Publicado: (2014)

Frequency of the virilising effects of attenuated androgens reported by women with hereditary angioedema
por: Zotter, Zsuzsanna, et al.
Publicado: (2014)

455 Characterization of the Factors Triggering an Edematous Attack in Hereditary Angioedema
por: Zotter, Zsuzsanna, et al.
Publicado: (2012)

Biochemical comparison of four commercially available C1 esterase inhibitor concentrates for treatment of hereditary angioedema
por: Feussner, Annette, et al.
Publicado: (2014)

Self-administered C1 esterase inhibitor concentrates for the management of hereditary angioedema: usability and patient acceptance
por: Li, Huamin Henry
Publicado: (2016)

Managing Diagnosis, Treatment, and Burden of Disease in Hereditary Angioedema Patients with Normal C1-Esterase Inhibitor
por: Jones, Douglas, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_uqgtthj1er6ct3f2pub3pj4utv